Medicare Enrolled
Dr. Guillermo Valenzuela, MD
Optician · Plantation, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Valenzuela from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Valenzuela?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Valenzuela
Dr. Guillermo Valenzuela is an optician specialist in Plantation, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Valenzuela performed 4,126 Medicare services across 1,512 unique beneficiaries.
Between the years covered by Open Payments, Dr. Valenzuela received a total of $1,706,291 from 74 pharmaceutical and/or device companies across 2882 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Valenzuela is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 21% volume in FL
$1,706,291 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 66617 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗4,126
Medicare services
Top 21% in FL for optician
1,512
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~217 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,260 | $18 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
984 | $97 | $232 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
214 | $0 | $5 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
203 | $94 | $307 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
173 | $9 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
122 | $131 | $366 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
115 | $87 | $236 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
114 | $55 | $164 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
104 | $50 | $117 |
| Tendon injection at attachment site A procedure involving the injection of medication into a tendon where it attaches to bone or muscle. |
91 | $43 | $135 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
90 | $48 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
89 | $10 | $55 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
70 | $22 | $65 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
47 | $4 | $15 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
46 | $20 | $68 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $67 | $158 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
36 | $1 | $5 |
| Ultrasound-guided small joint aspiration or injection This procedure involves removing fluid from or injecting medication into a small joint while using ultrasound imaging to guide the needle placement. |
35 | $58 | $108 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
35 | $24 | $82 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
33 | $76 | $244 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
26 | $16 | $67 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
25 | $28 | $124 |
| Injection, methylprednisolone acetate, 40 mg | 24 | $6 | $15 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
21 | $35 | $108 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
20 | $25 | $86 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
20 | $34 | $113 |
| Injection of carpal tunnel | 17 | $71 | $175 |
| MRI of arm joint, without contrast An MRI scan uses magnetic fields and radio waves to create detailed images of the arm joint. This specific procedure is performed without the use of a contrast dye. |
17 | $111 | $426 |
| MRI of arm without contrast An MRI scan of the arm that uses magnetic fields and radio waves to create detailed images of internal structures without the use of contrast dye. |
16 | $192 | $650 |
| X-ray of middle spine, 3 views An X-ray imaging test that captures three different views of the middle section of the spine to evaluate its structure. |
15 | $23 | $86 |
| MRI of leg joint, without contrast A magnetic resonance imaging scan of a joint in the leg performed without the use of contrast dye. |
15 | $122 | $484 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $127 | $310 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.1% high complexity
54.9% medium
34.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,706,291
Total received (2018-2024)
Avg $243,756/year across 7 years
Top 0% in FL for optician
74
Companies
2,882
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,223,231 (71.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$451,849 (26.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$31,211 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$214,820
2023
$246,203
2022
$176,537
2021
$163,468
2020
$171,097
2019
$317,814
2018
$416,352
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$248,155
GlaxoSmithKline, LLC.
$165,030
Amgen Inc.
$139,748
UCB, Inc.
$129,541
Horizon Therapeutics plc
$128,725
Novartis Pharmaceuticals Corporation
$115,918
GENZYME CORPORATION
$103,729
Janssen Scientific Affairs, LLC
$71,812
Celgene Corporation
$68,194
Boehringer Ingelheim Pharmaceuticals, Inc.
$53,484
Eli Lilly and Company
$50,930
Janssen Biotech, Inc.
$48,880
AstraZeneca Pharmaceuticals LP
$44,117
AbbVie, Inc.
$40,169
E.R. Squibb & Sons, L.L.C.
$38,425
ABBVIE INC.
$34,376
AbbVie Inc.
$33,995
NOVARTIS PHARMACEUTICALS CORPORATION
$32,208
Radius Health, Inc.
$29,943
Horizon Pharma plc
$25,892
Mallinckrodt LLC
$20,293
Eli Lilly Export S.A. Puerto Rico Branch
$19,483
Genentech USA, Inc.
$15,543
Aurinia Pharma U.S., Inc.
$11,257
Ironwood Pharmaceuticals, Inc
$7,532
PFIZER INC.
$6,404
Sandoz Inc.
$4,662
Regeneron Healthcare Solutions, Inc.
$4,170
Regeneron Pharmaceuticals, Inc.
$3,947
Takeda Pharmaceuticals U.S.A., Inc.
$2,580
Octapharma USA, Inc.
$2,107
Mallinckrodt Hospital Products Inc.
$808
Johnson & Johnson Health Care Systems Inc.
$685
UCB SA
$460
SANOFI-AVENTIS U.S. LLC
$422
MIMEDX Group, Inc.
$354
Gilead Sciences, Inc.
$254
Sobi, Inc
$195
Mallinckrodt Enterprises LLC
$168
Alexion Pharmaceuticals, Inc.
$166
Intercept Pharmaceuticals, Inc.
$147
ANI Pharmaceuticals, Inc.
$143
DePuy Synthes Sales Inc.
$117
Shire North American Group Inc
$77
Pacira Therapeutics, Inc.
$70
NeuroMetrix Inc
$69
BioCryst US Sales Co., LLC
$68
Alvogen Inc
$66
Ultragenyx Pharmaceutical Inc.
$59
Alnylam Pharmaceuticals Inc.
$55
Ferring Pharmaceuticals Inc.
$52
Organon LLC
$51
Actelion Pharmaceuticals US, Inc.
$38
Cumberland Pharmaceuticals, Inc.
$37
Endo Pharmaceuticals Inc.
$37
Kiniksa Pharmaceuticals, Ltd.
$33
Flexion Therapeutics, Inc.
$31
Relievant Medsystems, Inc.
$30
West-Ward Pharmaceuticals
$30
Genentech, Inc.
$30
MEDAC PHARMA, INC.
$28
Organon Llc
$27
Fidia Pharma USA Inc.
$24
SOBI, INC
$22
Pharming Healthcare, Inc.
$22
Fresenius Kabi USA, LLC
$21
GRT US Holding, Inc.
$21
FIDIA PHARMA USA INC.
$21
Bioventus LLC
$20
Kyowa Kirin, Inc.
$20
Mylan Institutional Inc.
$19
Zyla Life Sciences
$18
Teva Pharmaceuticals USA, Inc.
$15
MEDEXUS PHARMA, INC.
$14
Top 3 companies account for 32.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · CC-220 · COSENTYX · Cimzia · Crysvita · Cryvista · DUZALLO · Durolane · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · HUMIRA · HYALGAN · HYMOVIS · HYQVIA · Humira · ILARIS · INFLECTRA · Intracept · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NO PRODUCT DISCUSSED · NUCALA · OCALIVA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ONPATTRO · OPSUMIT · ORENCIA · ORLADEYO · ORTHOVISC · Orladeyo · Otezla · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolia · Qutenza · RAYOS · REDITREX · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · RUCONEST · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · Strensiq · TAKHZYRO · TALTZ · TAVNEOS · TEPEZZA · TERIPARATIDE · TREMFYA · Tavneos · Tremfya · Truxima · Tymlos · UPTRAVI · Uloric · XELJANZ · XIAFLEX · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for optician in FL.
Equivalent to $41,355 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
749
Per 100K population
38.5
County median income
$74,534
Nearest hospital
WESTSIDE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Valenzuela is a clinical cardiology specialist, with above-average Medicare volume (top 21% in FL), with speaking/promotional industry engagement in the top 0% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Valenzuela experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Valenzuela performed 1,260 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Valenzuela receive payments from pharmaceutical companies?
Yes. Dr. Valenzuela received a total of $1,706,291 from 74 companies across 2,882 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Valenzuela's costs compare to other opticians in Plantation?
Dr. Valenzuela's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Valenzuela) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Plantation
Browse opticians in Plantation ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology